Blueprint Medicines Pre-Tax Income 2014-2024 | BPMC

Blueprint Medicines pre-tax income for the twelve months ending September 30, 2024 was $-0.127B, a 76.95% decline year-over-year.

  • Blueprint Medicines annual pre-tax income for 2023 was $-0.506B, a 8.38% decline from 2022.
  • Blueprint Medicines annual pre-tax income for 2022 was $-0.552B, a 13.85% decline from 2021.
  • Blueprint Medicines annual pre-tax income for 2021 was $-0.641B, a 303.56% decline from 2020.

Blueprint Medicines Pre-Tax Income 2014-2024 | BPMC

  • Blueprint Medicines annual pre-tax income for 2023 was $-0.506B, a 8.38% decline from 2022.
  • Blueprint Medicines annual pre-tax income for 2022 was $-0.552B, a 13.85% decline from 2021.
  • Blueprint Medicines annual pre-tax income for 2021 was $-0.641B, a 303.56% decline from 2020.